This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 25/9/1917    most recent 01.ATV.0000174807.90292.2fv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schapira, K. Articles by Heeneman, S. Search for Related Content PubMed PubMed Citation Articles by Schapira, K. Articles by Heeneman, S.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1917.)
© 2005 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Genetic Deletion or Antibody Blockade of 1ß1 Integrin Induces a Stable Plaque Phenotype in ApoE–/– Mice

Kitty Schapira; Esther Lutgens; Antonin de Fougerolles; Andrew Sprague; Anouk Roemen; Humphrey Gardner; Victor Koteliansky; Mat Daemen; Sylvia Heeneman

From the Department of Pathology (K.S., E.L., A.R., M.D., S.H.), Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands; and Biogen Idec (A.d.F., A.S., H.G., V.K.) and Alnylam Pharmaceuticals (A.d.F., A.S., V.K.), Cambridge, Mass.

Correspondence to S. Heeneman, PhD, Department of Pathology, P. Debeyelaan 25, 6229 HX Maastricht, The Netherlands. E-mail sheen{at}lpat.azm.nl

Objective— Adhesive interactions between cells and the extracellular matrix play an important role in inflammatory diseases like atherosclerosis. We investigated the role of the collagen-binding integrin 1ß1 in atherosclerosis.

Methods and Results— ApoE–/– mice were 1-deficient or received early or delayed anti-1 antibody treatment. Deficiency in 1 integrin reduced the area of atherosclerotic plaques and altered plaque composition by reducing inflammation and increasing extracellular matrix. In advanced plaques, 1-deficient mice had a reduced macrophage and CD3+ cell content, collagen and smooth muscle cell content increased, lipid core sizes decreased, and cartilaginous metaplasia occurred. Anti-1 antibody treatment reduced the macrophage content in initial plaques after early and delayed treatment, decreased the CD3+ cell content in advanced plaques after delayed treatment, and increased the collagen content in initial and advanced plaques after delayed treatment. Migration assays performed on 1-deficient macrophages on collagen I and IV substrata revealed that 1-deficient cells can migrate on collagen I, but not IV. Anti-1 antibody treatment of ApoE–/– macrophages also inhibited migration of cells on collagen IV.

Conclusions— Our results suggest that 1ß1 integrin is involved in atherosclerosis by mediating the migration of leukocytes to lesions by adhesion to collagen IV. Blocking this integrin reduces atherosclerosis and induces a stable plaque phenotype.

The role of 1ß1 integrin was investigated in atherosclerosis. 1ß1 integrin is involved in atherosclerosis by mediating the migration of leukocytes to lesions via adhesion to collagen IV. Blocking this integrin reduces atherosclerosis and induces a more stable plaque phenotype.

Key Words: atherosclerosis • macrophages • extracellular matrix • collagen • integrin

This article has been cited by other articles:

				E. Adiguzel, P. J Ahmad, C. Franco, and M. P Bendeck Collagens in the progression and complications of atherosclerosis Vascular Medicine, February 1, 2009; 14(1): 73 - 89. [Abstract] [PDF]

				A. L. Pyle, J. B. Atkinson, A. Pozzi, J. Reese, B. Eckes, J. M. Davidson, D. L. Crimmins, and P. P. Young Regulation of the Atheroma-Enriched Protein, SPRR3, in Vascular Smooth Muscle Cells through Cyclic Strain is Dependent on Integrin {alpha}1{beta}1/Collagen Interaction Am. J. Pathol., November 1, 2008; 173(5): 1577 - 1588. [Abstract] [Full Text] [PDF]

				C. Franco, G. Hou, P. J. Ahmad, E. Y.K. Fu, L. Koh, W. F. Vogel, and M. P. Bendeck Discoidin Domain Receptor 1 (Ddr1) Deletion Decreases Atherosclerosis by Accelerating Matrix Accumulation and Reducing Inflammation in Low-Density Lipoprotein Receptor-Deficient Mice Circ. Res., May 23, 2008; 102(10): 1202 - 1211. [Abstract] [Full Text] [PDF]

				H. Louis, A. Kakou, V. Regnault, C. Labat, A. Bressenot, J. Gao-Li, H. Gardner, S. N. Thornton, P. Challande, Z. Li, et al. Role of {alpha}1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2597 - H2604. [Abstract] [Full Text] [PDF]

				N. Ferri, G. Colombo, C. Ferrandi, E. W. Raines, B. Levkau, and A. Corsini Simvastatin Reduces MMP1 Expression in Human Smooth Muscle Cells Cultured on Polymerized Collagen by Inhibiting Rac1 Activation Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1043 - 1049. [Abstract] [Full Text] [PDF]